This is supported by a study by Maeda et al., which reported that patients carrying the SLCO1B1 *1b allele had a lower prevalence of drug-induced adverse reactions such as increased AST levels and anemia (Maeda et al., 2017). This evidence concerns the gene SLCO1B1 and anemia (phenotype).